Influenza virus delta NS1 vaccine

Drug Profile

Influenza virus delta NS1 vaccine

Alternative Names: deltaFLU LAIV; deltaFLU quadrivalent LAIV; FluVacc; FluVacc - DNS1; Fluvacc delta NS1; FLUVACCdelNS1; FluVaccΔNS1; GHB01L1; GHB04L1; GHB11L1; GHB16L2; H5N1 influenza virus vaccine; Influenza A virus vaccine H1N1; Intranasal H5N1 vaccine - Avir Green Hills Biotechnology; Pandemic avian flu vaccine - Avir Green Hills Biotechnology; Seasonal influenza vaccine deltaFLU; Seasonal influenza virus vaccine Green Hills - Biotechnology

Latest Information Update: 09 Apr 2018

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Green Hills Biotechnology
  • Developer Vivaldi Biosciences
  • Class Antivirals; Influenza virus vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase II Influenza virus infections

Most Recent Events

  • 04 Apr 2018 Pharmacodynamics data from a preclinical study in Influenza virus infections released by Vivaldi Biosciences
  • 12 Feb 2018 Pharmacodynamics data from a preclinical study in Influenza virus infections released by Vivaldi Biosciences
  • 06 Aug 2015 Phase-II development is ongoing in Austria
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top